Biomarin Pharmaceutical Equity Dashboard

Far too much social signal, news, headlines, and media speculation about Biomarin Pharmaceutical that are available to investors today. That information is available publicly through Biomarin media outlets and privately through word of mouth or via Biomarin internal channels. However, regardless of the origin, that massive amount of Biomarin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biomarin Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biomarin Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biomarin Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biomarin Pharmaceutical alpha.

Biomarin Stock Historical Chart

Most investors accept the general idea that the market moves back and forth in trends. These trends are simply referred to as bull and bear market cycles. Each bull market begins after a day that signals the beginning of a new uptrend, whereas every bear market starts after the long-term downward trend is projected forward. Using Biomarin Pharmaceutical stock market historical data and studying specific examples from the stock market past, makes it easier to put current market moves in context, while making an informed buy or sell decision.
BMRN Stock  USD 88.61  0.87  0.99%   
The Biomarin Pharmaceutical Equities Center is a collection of modules for Biomarin Pharmaceutical equity research and analysis. Using equity center you examine different market driven as well as company-specific characteristics using powerful technical, fundamental, predictive and other Biomarin Pharmaceutical specific modules. Please select from the options below.
This is a quick snapshot of Biomarin Pharmaceutical research areas. You can expand your research by examining different market driven as well as company-specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and many other powerfull tools.
Quote & Profile

Quote & Profile

Biomarin Pharmaceutical profile, quote, and daily performance
Updated
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for Biomarin Pharmaceutical
Event Calendar

Event Calendar

Calendar of corporate events and headlines for Biomarin Pharmaceutical
Updated
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for Biomarin Pharmaceutical
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for Biomarin Pharmaceutical
Updated
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for Biomarin Pharmaceutical
Chance of Bankruptcy

Chance of Bankruptcy

Biomarin Pharmaceutical chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different Biomarin Pharmaceutical historical pattern-recognition indicators
Current Valuation

Current Valuation

Biomarin Pharmaceutical valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

Biomarin Pharmaceutical current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze Biomarin Pharmaceutical Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

Biomarin Pharmaceutical volatility and risk analysis compared to market
Updated
Correlation With Market

Correlation With Market

Biomarin Pharmaceutical correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

Biomarin Pharmaceutical in the context of related companies
Management

Management

Biomarin Pharmaceutical leadership and management evaluation
Performance

Performance

Risk-adjusted expected returns and performance analysis
Risk-adjusted Advice

Risk-adjusted Advice

Personalized buy or sell advice on Biomarin Pharmaceutical
Power Widgets

Power Widgets

Macroaxis widgets syndication for Biomarin Pharmaceutical
Price Prediction

Price Prediction

Basic Biomarin Pharmaceutical price forecast based on headlines and hype
Updated
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for Biomarin Pharmaceutical
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of Biomarin Pharmaceutical
Fundamental History

Fundamental History

Biomarin Pharmaceutical history of fundamentals from various financial
Revenue

Revenue

Relative Biomarin Pharmaceutical revenue analysis
Updated
Net Income Analysis

Net Income Analysis

Biomarin Pharmaceutical income analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on Biomarin Pharmaceutical operations
Balance Of Power

Balance Of Power

Daily balance of power indicator of Biomarin Pharmaceutical
Price History

Price History

Biomarin Pharmaceutical daily price history and news impact
Updated
Pair Correlation

Pair Correlation

Correlation between Biomarin Pharmaceutical and Old Dominion
BMRN vs. FIZZ

BMRN vs. FIZZ

Fundamentals comparison between Biomarin Pharmaceutical and National Beverage